Celnovte

Home

Solution

PUBLICATIONS

Powering Precision Pathology: Celnovte Antibodies Featured in Latest Lung Tumor Breakthrough

2026-01-26

By celnovte

Powering Precision Pathology: Celnovte Antibodies Featured in Latest Lung Tumor Breakthrough
We are thrilled to see Celnovte reagents contributing to cutting-edge research published in Human Pathology (2025)!
A research team from The First Affiliated Hospital of Guangzhou Medical University has successfully characterized the molecular spectrum of Ciliated Muconodular Papillary Tumors (CMPT), revealing a novel COX7C::ALK rearrangement for the first time.
Accurate diagnosis of CMPT requires distinguishing it from mimics like invasive mucinous adenocarcinoma. The key? Identifying the continuous basal cell layer.
We are proud that Celnovte’s P63 (Clone C2C10) and CK5/6 (Clone C6H1) antibodies were selected to validate these critical basal cell markers, ensuring precise histomorphological assessment.
At Celnovte, we are dedicated to providing high-quality, reliable staining solutions that empower pathologists and researchers to uncover the unknown.